PH12013500219A1 - Compounds with antibacterial activity against clostridium - Google Patents

Compounds with antibacterial activity against clostridium

Info

Publication number
PH12013500219A1
PH12013500219A1 PH1/2013/500219A PH12013500219A PH12013500219A1 PH 12013500219 A1 PH12013500219 A1 PH 12013500219A1 PH 12013500219 A PH12013500219 A PH 12013500219A PH 12013500219 A1 PH12013500219 A1 PH 12013500219A1
Authority
PH
Philippines
Prior art keywords
compounds
activity against
antibacterial activity
against clostridium
clostridium
Prior art date
Application number
PH1/2013/500219A
Other languages
English (en)
Inventor
Jerã´Me Emile Georges Guillemont
Nacer Lounis
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Elanco Animal Health Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Ireland filed Critical Elanco Animal Health Ireland
Publication of PH12013500219A1 publication Critical patent/PH12013500219A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH1/2013/500219A 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium PH12013500219A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171842 2010-08-04
PCT/EP2011/063434 WO2012017030A1 (en) 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium

Publications (1)

Publication Number Publication Date
PH12013500219A1 true PH12013500219A1 (en) 2013-02-25

Family

ID=43125618

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2013/500219A PH12013500219A1 (en) 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium

Country Status (28)

Country Link
US (1) US8618100B2 (enExample)
EP (1) EP2601193B1 (enExample)
JP (1) JP5886285B2 (enExample)
KR (1) KR101499368B1 (enExample)
CN (1) CN103038234B (enExample)
AR (1) AR082472A1 (enExample)
AU (1) AU2011287584B2 (enExample)
BR (1) BR112013003675A8 (enExample)
CA (1) CA2805358C (enExample)
CL (1) CL2013000331A1 (enExample)
CO (1) CO6680629A2 (enExample)
CY (1) CY1116238T1 (enExample)
DK (1) DK2601193T3 (enExample)
EA (1) EA021567B1 (enExample)
ES (1) ES2538998T3 (enExample)
HR (1) HRP20150467T1 (enExample)
ME (1) ME02061B (enExample)
MX (1) MX2013001246A (enExample)
NZ (1) NZ605850A (enExample)
PH (1) PH12013500219A1 (enExample)
PL (1) PL2601193T3 (enExample)
PT (1) PT2601193E (enExample)
RS (1) RS53990B1 (enExample)
SG (1) SG187175A1 (enExample)
SI (1) SI2601193T1 (enExample)
TW (1) TWI498330B (enExample)
WO (1) WO2012017030A1 (enExample)
ZA (1) ZA201300432B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
US20180000793A1 (en) * 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법
US12220421B2 (en) 2021-09-09 2025-02-11 The Boards Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Inhibitors of C. difficile spore germination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101652140B (zh) * 2006-09-26 2013-07-10 克莱斯通公司 具有抗菌活性的对映体化合物
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection
WO2008039639A2 (en) 2006-09-26 2008-04-03 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity

Also Published As

Publication number Publication date
ZA201300432B (en) 2014-08-27
MX2013001246A (es) 2013-03-21
EA201270817A1 (ru) 2013-05-30
WO2012017030A1 (en) 2012-02-09
CY1116238T1 (el) 2017-02-08
CA2805358A1 (en) 2012-02-09
PL2601193T3 (pl) 2015-08-31
HRP20150467T1 (hr) 2015-06-05
JP5886285B2 (ja) 2016-03-16
PT2601193E (pt) 2015-05-18
AU2011287584B2 (en) 2014-05-01
DK2601193T3 (en) 2015-03-23
ME02061B (me) 2015-05-20
ES2538998T3 (es) 2015-06-25
AU2011287584A1 (en) 2013-02-07
CL2013000331A1 (es) 2013-06-28
RS53990B1 (sr) 2015-10-30
CA2805358C (en) 2016-02-16
HK1180690A1 (en) 2013-10-25
US20130109694A1 (en) 2013-05-02
EA021567B1 (ru) 2015-07-30
KR20130033440A (ko) 2013-04-03
AR082472A1 (es) 2012-12-12
TWI498330B (zh) 2015-09-01
SI2601193T1 (sl) 2015-05-29
TW201211048A (en) 2012-03-16
US8618100B2 (en) 2013-12-31
NZ605850A (en) 2014-07-25
CN103038234B (zh) 2016-02-24
JP2013532714A (ja) 2013-08-19
SG187175A1 (en) 2013-02-28
BR112013003675A2 (pt) 2016-09-06
EP2601193B1 (en) 2015-03-11
EP2601193A1 (en) 2013-06-12
BR112013003675A8 (pt) 2017-12-26
CO6680629A2 (es) 2013-05-31
CN103038234A (zh) 2013-04-10
KR101499368B1 (ko) 2015-03-05

Similar Documents

Publication Publication Date Title
MX2011005934A (es) Compuestos organicos.
MX336381B (es) Boronatos como inhibidores de arginasa.
UA104885C2 (uk) Ізотіазолілоксифеніламідини та їх застосування як фунгіцидів
UA118182C2 (uk) Дифторметилнікотинові інданілкарбоксаміди
PH12014500317A1 (en) Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
PH12013502434A1 (en) Substituted pyridopyrazines as novel syk inhibitors
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2015001834A (es) Nuevos compuestos antibacterianos.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
MX2015001835A (es) Nuevos compuestos antibacterianos.
MX2014001598A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con homopiperidinilo antibacterianas.
EA201270817A1 (ru) Соединения, обладающие антибактериальной активностью в отношении clostridium
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.
MX2013002398A (es) Inhibidores de beta-secretasa (base) para su uso en tratamiento de diabetes.
MX2012004282A (es) Composiciones farmaceuticas.
PH12015501428A1 (en) Antibacterial compounds
TN2011000617A1 (en) 17 - alkyl-17 -oxy-oestratrienes
UA38601U (en) 2,2'-dithioxo-4,4'-dioxo-[5,5']-bithiazolidinyl-idene-diyl-3,3'-dibutanoic acid diarylamides having antitumor activity
TN2011000248A1 (en) Organic compounds
TN2010000583A1 (en) Organic compounds
UA45737U (ru) ЦИКЛОПЕНТИЛИДЕН-ГИДРАЗИД α-ПИРИДИНКАРБОНОВОЙ КИСЛОТЫ, ВЫЯВЛЯЮЩИЙ ПротивотуберкулезнУЮ АКТИВНОСТЬ
MY182136A (en) Pharmaceutical compositions
UA94136C2 (ru) Н-бутиламид 4-метил-7-хлор-2-оксо-1,2-дигмдрохинолин-6-сульфоновой кислоты, проявляющий диуретическую активность